TD Private Client Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$169	Hold	3	–	–	﹤0.01%	1589
2025 Q4	$178	Buy	+3	New	+$163	﹤0.01%	1544
2025 Q3	–	Sell	-504	Closed	-$27.7K	–	1540
2025 Q2	$27.7K	Sell	504 -178	-26%	-$10.5K	﹤0.01%	941
2025 Q1	$48.2K	Buy	682 +46	+7%	+$3.1K	﹤0.01%	819
2024 Q4	$41.8K	Buy	636 +126	+25%	+$8.44K	﹤0.01%	856
2024 Q3	$35.8K	Buy	510 +186	+57%	+$15.5K	﹤0.01%	888
2024 Q2	$26.7K	Buy	324 +75	+30%	+$6.24K	﹤0.01%	907
2024 Q1	$21.7K	Buy	249 +108	+77%	+$9.67K	﹤0.01%	939
2023 Q4	$13.6K	Buy	141 +24	+21%	+$2.12K	﹤0.01%	1010
2023 Q3	$10.4K	Buy	117 +11	+10%	+$979	﹤0.01%	1026
2023 Q2	$9.19K	Buy	106 +26	+33%	+$2.45K	﹤0.01%	1064
2023 Q1	$7.78K	Buy	80 +14	+21%	+$1.45K	﹤0.01%	1064
2022 Q4	$6.83K	Buy	66 +10	+18%	+$939	﹤0.01%	1053
2022 Q3	$4.75K	Hold	56	–	–	﹤0.01%	1063
2022 Q2	$4.64K	Hold	56	–	–	﹤0.01%	1080
2022 Q1	$4.32K	Sell	56 -14	-20%	-$1.17K	﹤0.01%	1109
2021 Q4	$6.18K	Buy	70 +30	+75%	+$2.48K	﹤0.01%	942
2021 Q3	$3.09K	Sell	40 -8	-17%	-$631	﹤0.01%	996
2021 Q2	$4K	Buy	48 +11	+30%	+$872	﹤0.01%	977
2021 Q1	$2.79K	Buy	37 +15	+68%	+$1.23K	﹤0.01%	980
2020 Q4	$1.93K	Buy	22 +4	+22%	+$317	﹤0.01%	961
2020 Q3	$1.37K	Buy	18 +10	+125%	+$1.01K	﹤0.01%	941
2020 Q2	$987	Sell	8 -27	-77%	-$2.68K	﹤0.01%	960
2020 Q1	$2.96K	Hold	35	–	–	﹤0.01%	849
2019 Q4	$2.96K	Buy	+35	New	+$2.64K	﹤0.01%	871